MDWD

MediWound Ltd. is a leading biopharmaceutical company based in Yavne, Israel, dedicated to developing and commercializing innovative biotherapeutic solutions for tissue repair and regeneration. The company’s flagship product, NexoBrid, represents a transformative advance in burn treatment, underscoring its commitment to fulfilling unmet medical needs within the wound care sector. With a strategic focus on pioneering therapies and the potential for significant growth in the dynamically evolving healthcare market, MediWound offers an attractive investment opportunity for institutional investors looking to gain exposure to the future of advanced regenerative medicine.